[1]蒋金桃,崔国良,冯小可,等.扁蒴藤素对肺纤维化模型小鼠肺组织形态及转化生长因子-β1、α-平滑肌肌动蛋白表达的影响[J].中国中医药信息杂志,2020,27(4):41-45.[doi:10.3969/j.issn.1005-5304.201910238]
 JIANG Jintao,CUI Guoliang,FENG Xiaoke,et al.Effects of Pristimerin on Morphology of Lung Tissue and Expressions of TGF- 1 and -SMA of Pulmonary Fibrosis Model Mice[J].zhongguo zhongyiyao xinxi zazhi,2020,27(4):41-45.[doi:10.3969/j.issn.1005-5304.201910238]
点击复制

扁蒴藤素对肺纤维化模型小鼠肺组织形态及转化生长因子-β1、α-平滑肌肌动蛋白表达的影响

参考文献/References:

[1] ATZENNI F, GERARDI M C, BARILARO G, et al. Interstitial lung disease in systemic autoimmune rheumatic diseases:a comprehensive review[J]. Expert Rev Clin Immunol,2018,14(1):69-82.

[2] SIBINSKA, TIAN X, KOERFEI M. Amplified canonical transforming growth factor-β signalling via heat shock protein 90 in pulmonary fibrosis[J]. Eur Respir J,2017,49(2):1501941.

[3] AMO A I, GAUGLITZ G G, BARRET J P, et al. New molecular medicine- based scar management strategies[J]. Burns,2014,40(4):539.

[4] FISCHER A, BALJULS A, REINDERS J, et al. Regulation of RAF activity by 14-3-3 proteins[J]. Journal of Biological Chemistry, 2008,284(5):3183-3194.

[5] RAGHU G, ROCHWERG B, ZHANG Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline:treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline[J]. Am J Respir Crit Care Med,2015,192(2):e3-e19.

[6] BLAAUBOER M E, BOEIJEN F R, EMSON C L, et al. Extracellular matrix proteins:a positive feedback loop in lung fibrosis?[J]. Matrix Biol,2014,34:170-178.

[7] 白殊同,佟丽,王琴,等.过山枫活性成分扁蒴藤素药理作用研究进展[J].中国药理学通报,2019,35(3):318-321.

[8] EI-AGAMY D S, EI-HARBI K M, KHOSHHAL S, et al. Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-κB signaling pathways[J]. Cancer Manag Res,2019,11:47-61.

[9] CABRERA S, MACIEL M, HERRERA I, et al. Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis[J]. Autophagy,2015,11(4):670-694.

[10] SZAPIEL S V, ELSON N A, FULMER J D, et al. Bleomycin-induced interstitial pulmonary disease in the nude athymic mouse[J]. Am Rev Respir Dis,1979,120(4):893-899.

[11] ASHCROFT T, SIMOSON J M, TIMBRELL V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale[J]. J Clin Pathol,1988,41(4):467-470.

[12] SAKAI N, TAGER A M. Fibrosis of two:epithelial cell-fibroblast interactions in pulmonary fibrosis[J]. Biochim Biophys Acta, 2013,1832(7):911-921.

[13] CHIOMA O S, DRAKE W P. Role of microbial agents in pulmonary fibrosis[J]. Yale J Biol Med,2017,90(2):219-227.

[14] 崔园园.特发性肺纤维化患者血清TGF-β1、STAT1表达水平及临床意义[D].济南:山东大学,2019.

[15] SAITO A, HORIE M, MICKE P, et al. The role of TGF-beta signaling in lung cancer associated with idiopathic pulmonary fibrosis[J]. Int J Mol Sci,2018,19(1):147.

[16] BAGALAD B S, MOHAN KUMAR K P. Myofibroblasts:Master of disguise[J]. J Oral Maxillofac Pathol,2017,21(3):462-463.

[17] DERBY I A, ZAKUAN N, BILLET F. The myofibroblast, a key cell in normal and pathological tissue repair[J]. Cell Mol Life Sci, 2016,73(6):1145-1157.

[18] 孙林清,周倩文,王发选.转化生长因子β1对肺成纤维细胞中平滑肌肌动蛋白表达的影响[J].宁夏医科大学学报,2019,41(5):461-464.

[19] TONG L, NANJUNDAIAH S M, VENKATESHA S H. Pristimerin,a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage[J]. Clin Immunol,2014,155(2)220-230.

[20] HISHIKARI K, WATANABE R, OGAWA M, et al. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity[J]. Heart,2010, 96(7):523-527.

相似文献/References:

[1]张天嵩,张素,李秀娟,等.治疗肺纤维化中药复方用药规律的数据挖掘[J].中国中医药信息杂志,2011,18(2):31.[doi:10.3969/j.issn.1005-5304.2011.02.014]
 ZHANG Tian-song,ZHANG Su,LI Xiu-juan,et al.Data Mining of the Regularity of Compound Herbal Formulae for Pulmonary Fibrosis[J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):31.[doi:10.3969/j.issn.1005-5304.2011.02.014]
[2]宋建平,李伟,刘方州,等.金匮肾气丸对肺纤维化大鼠肺组织转化生长因子β1表达的影响[J].中国中医药信息杂志,2007,14(2):29.
 SONG Jian-Ping,LI Wei,LIU Fang-Zhou,et al.Effect of Jinguishenqi Wan on TGF-β1 Expression in Lung of Pulmonary Fibrosis Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(4):29.
[3]龚婕宁,郭海,魏凯峰,等.养肺活血方对肺纤维化大鼠细胞外信号调节激酶1/2和核因子κ-B信号通路的影响[J].中国中医药信息杂志,2009,16(11):21.
 GONG Jie-ning,GUO Hai,WEI Kai-feng,et al.Effect of Yangfei Huoxue Prescription on ERK1/2 and NFκ-B of Bleomycin-induced Pulmonary Fibrosis in Rats[J].zhongguo zhongyiyao xinxi zazhi,2009,16(4):21.
[4]尹玲慧,于永铎.培土生金化瘀法治疗肺纤维化理论探讨[J].中国中医药信息杂志,2008,15(1):90.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):90.
[5]张立山,戴雁彦,任传云.武维屏教授治疗肺纤维化十法[J].中国中医药信息杂志,2008,15(4):94.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):94.
[6]王步青,薛勤梅.肺络理论与肺纤维化关系探讨[J].中国中医药信息杂志,2008,15(11):93.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):93.
[7]施剑.培土通络法治疗肺纤维化理论探讨[J].中国中医药信息杂志,2007,14(7):89.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(4):89.
[8]汪玉冠,指导:宋康.肺纤维化中医药研究进展[J].中国中医药信息杂志,2007,14(11):97.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(4):97.
[9]胡静,郭永洁,刘旭凌,等.凉血活血法对肺纤维化小鼠羟脯氨酸和转化生长因子-β1含量的影响[J].中国中医药信息杂志,2009,16(9):25.
 HU Jing,GUO Yong-jie,LIU Xu-ling,et al.Effect of Cooling Blood and Invigorating Circulation Method on Content of Hydroxyproline and TGF-β1 in Pulmonary Fibrosis Mice[J].zhongguo zhongyiyao xinxi zazhi,2009,16(4):25.
[10]郭书文,王国华,杨蟠储,等.益气活血化痰方对肺纤维化大鼠支气管肺泡灌洗液中层粘连蛋白、Ⅲ型前胶原含量的影响[J].中国中医药信息杂志,2006,13(11):43.
 GUO Shu-wen,WANG Guo-hua,YANG Pan-chu,et al.Influence of Complex Prescription of Replenishing Qi, Activating Blood and Resolving Phlegm on the Levels of LN and PC-Ⅲ in BALF in Rat Model of Pulmonary Fibrosis[J].zhongguo zhongyiyao xinxi zazhi,2006,13(4):43.

备注/Memo

基金项目:国家自然科学基金面上项目(81774104、8197532);国家自然科学基金青年基金(81403240)

更新日期/Last Update:

2020-03-20